Ambrx Biopharma, Inc. (AMAM)
Total Valuation
AMAM has a market cap or net worth of $148.57 million. The enterprise value is -$9.21 million.
| Market Cap | 148.57M |
| Enterprise Value | -9.21M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AMAM has 38.59 million shares outstanding.
| Shares Outstanding | 38.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 51.08% |
| Float | 14.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.93 |
| PB Ratio | 0.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.07.
| Current Ratio | 7.19 |
| Quick Ratio | 7.00 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -269.40%, which is considered low. The company has a ROIC of -2,080.00%.
| Return on Equity (ROE) | -269.40% |
| Return on Assets (ROA) | -37.50% |
| Return on Capital (ROIC) | -2,080.00% |
| Revenue Per Employee | $92,037 |
| Profits Per Employee | -$840,481 |
| Employee Count | 81 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AMAM has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -78.61% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 6.37 |
| Average Volume (30 Days) | 6,958 |
Short Selling Information
The latest short interest is 5,598, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 5,598 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.60 |
Income Statement
In the last 12 months, AMAM had revenue of $7.46 million and -68.08 million in losses. Earnings per share was -$3.33.
| Revenue | 7.46M |
| Gross Profit | 7.46M |
| Operating Income | -64.42M |
| Pretax Income | -68.08M |
| Net Income | -68.08M |
| EBITDA | -64.34M |
| EBIT | -68.08M |
| Earnings Per Share (EPS) | -$3.33 |
Balance Sheet
The company has $170.91 million in cash and $13.13 million in debt, giving a net cash position of $157.78 million or $4.09 per share.
| Cash & Cash Equivalents | 170.91M |
| Total Debt | 13.13M |
| Net Cash | 157.78M |
| Net Cash Per Share | $4.09 |
| Book Value | 189.97M |
| Book Value Per Share | 4.92 |
| Working Capital | 152.23M |
Cash Flow
In the last 12 months, operating cash flow was -$44.64 million and capital expenditures -$1.96 million, giving a free cash flow of -$46.60 million.
| Operating Cash Flow | -44.64M |
| Capital Expenditures | -1.96M |
| Free Cash Flow | -46.60M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -864.17% and -913.20%.
| Gross Margin | 100.00% |
| Operating Margin | -864.17% |
| Pretax Margin | -913.19% |
| Profit Margin | -913.20% |
| EBITDA Margin | -863.07% |
| EBIT Margin | -913.19% |
| FCF Margin | -625.03% |
Dividends & Yields
AMAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -45.82% |
| FCF Yield | -31.36% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
The average price target for AMAM is $14.62, which is 279.74% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.62 |
| Price Target Difference | 279.74% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |